Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
5 hours ago
- #FDA
- #Obesity Drug
- #Donald Trump
- A 79-year-old patient gained early access to Eli Lilly's weight-loss drug retatrutide via the FDA's compassionate use program.
- The patient's identity is unknown, but signs suggest high-level connections, leading to speculation it could be Donald Trump.
- The White House did not explicitly deny Trump was the patient, and his medical evaluation does not mention the cited conditions.
- The patient had refractory obesity with obstructive sleep apnea and pulmonary hypertension, and had tried other drugs with limited success.
- FDA's program allows access to experimental drugs for serious conditions when no approved alternatives exist, reviewed case-by-case.